Prethrombin-1

Bio&Bio is seeking strategic partners to advance the clinical and commercial development of Prethrombin-1.
Bio&Bio is a privately held biomedical company with a strong scientific legacy in coagulation and plasma-derived therapies. Building on decades of expertise, the company offers partners access to a focused, high-potential hemostatic development candidate addressing a clear unmet medical need in acute bleeding management.
Bio&Bio is open to flexible partnering models, including licensing, co-development, and strategic collaborations.